Processes for treating toxicities associated with administering a therapeutic agent to a mammal, for treating toxicities associated with a mammal's exposure to radiation therapy, for treating neuro- or nephrodisturbs in a human, and for treating disorders and clinical symptoms associated with type i or type ii diabetes in a human

摘要

"PROCESSES FOR THE TREATMENT OF TOXICITIES ASSOCIATED WITH THE ADMINISTRATION OF A THERAPEUTIC AGENT TO A MAMMALIAN, FOR TREATMENT OF TOXICITIES ASSOCIATED WITH THE EXPOSURE OF A MAMMALIAN TO RADIATION THERAPY, FOR TREATMENT OF NEURO- OR HYDRO-TREATMENT, HUMAN AND HUMAN REHABILITATION, HUMAN AND HUMAN TREATMENT. CLINICAL DISTURBANTS AND SYMPTOMS ASSOCIATED WITH TYPE I OR TYPE II DIABETES IN A HUMAN ". The present invention relates to the new uses of S-2- (3-amino-propyl-amino) -ethyl dihydrogen-phosphorus-thioate (amifistin) and other amino-thiol compounds to treat and reverse toxicity caused by therapeutic agents, radiation treatment and diabetes. In particular, the invention provides a process for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.